However, p90 protein was overexpressed in 55% of human gastric cancer tissues, and anti-p90 auto-antibodies were detected in patients with hepatocellular carcinoma (13.1%), but not in patients with chronic hepatitis and acute hepatitis, HBsAg carriers, or normal controls. Here, CIP2A is linked to chronic hepatitis.